Drug Discovery serves as the upstream core of new drug development, which identifies therapeutic targets and validates candidate molecules via in vitro functional assays to lay the foundation for subsequent preclinical research. Our integrated Drug Discovery portfolio delivers full-spectrum research tools for the entire early development pipeline: high-quality therapeutic target proteins and antibodies for target discovery and validation; unique series of standardized in vitro assay kits including OneStep ELISA, StepSlim ELISpot, homogeneous immuno-chemiluminescence, UniOne TR-FRET and UA-Glo luciferase assays for high-throughput screening and pharmacodynamic verification; complete reagent packages for ADC site-specific conjugation & characterization as well as full-process CAR-T cell functional evaluation, streamlining experimental workflows and speeding up the R&D of small molecules, antibodies, ADCs and cell therapeutics.